Monocyte chemotactic protein-1 promotes the myocardial homing of mesenchymal stem cells in dilated cardiomyopathy

International Journal of Molecular Sciences

Volumn 14, Issue 4, 2013, Pages 8164-8178

  Guo, Jing ^a   Zhang, Haifeng ^a   Xiao, Junjie ^a,b   Wu, Jian ^c   Ye, Yong ^c   Li, Zheng ^c   Zou, Yunzeng ^c   Li, Xinli ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b SHANGHAI UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Dilated cardiomyopathy; Homing; Mesenchymal stem cells; Monocyte chemotactic protein 1; Myocardial

Indexed keywords

CHEMOKINE RECEPTOR CCR2; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; STROMAL CELL DERIVED FACTOR 1; CCL2 PROTEIN, MOUSE; CCL3 PROTEIN, MOUSE; CCL7 PROTEIN, MOUSE; CCR2 PROTEIN, MOUSE; CXCL12 PROTEIN, MOUSE; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL HOMING; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FLOW CYTOMETRY; HEART CONTRACTION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE FIBROSIS; HEART VENTRICLE SIZE; IN VITRO STUDY; IN VIVO STUDY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MIGRATION INHIBITION; MOUSE; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; THERAPY EFFECT; UPREGULATION; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CARDIOMYOPATHY, DILATED; CELL MOTION; DISEASE MODEL; GENETICS; HEART MUSCLE; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

MUS;

ANIMALS; CARDIOMYOPATHY, DILATED; CELL MOVEMENT; CHEMOKINE CCL2; CHEMOKINE CCL3; CHEMOKINE CCL7; CHEMOKINE CXCL12; DISEASE MODELS, ANIMAL; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; MYOCARDIUM; RECEPTORS, CCR2; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84877017142     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms14048164     Document Type: Article

References (36)

1. Mozid, A.M.; Arnous, S.; Sammut, E.C.; Mathur, A. Stem cell therapy for heart diseases. Br. Med. Bull. 2011, 98, 143-159.
2. Cowie, M.R.; Zaphiriou, A. Management of chronic heart failure. BMJ 2002, 325, 422-425.
3. Fox, K.F.; Cowie, M.R.; Wood, D.A.; Coats, A.J.; Gibbs, J.S.; Underwood, S.R.; Turner, R.M.; Poole-Wilson, P.A.; Davies, S.W.; Sutton, G.C. Coronary artery disease as the cause of incident heart failure in the population. Eur. Heart J. 2001, 22, 228-236.
4. Cowie, M.R.; Mosterd, A.; Wood, D.A.; Deckers, J.W.; Poole-Wilson, P.A.; Sutton, G.C.; Grobbee, D.E. The epidemiology of heart failure. Eur. Heart J. 1997, 18, 208-225.
5. Baba, S.; Heike, T.; Yoshimoto, M.; Umeda, K.; Doi, H.; Iwasa, T.; Lin, X.; Matsuoka, S.; Komeda, M.; Nakahata, T. Flk1(+) cardiac stem/progenitor cells derived from embryonic stem cells improve cardiac function in a dilated cardiomyopathy mouse model. Cardiovasc. Res. 2007, 76, 119-131.
6. Schenk, S.; Mal, N.; Finan, A.; Zhang, M.; Kiedrowski, M.; Popovic, Z.; McCarthy, P.M.; Penn, M.S. Monocyte chemotactic protein-3 is a myocardial mesenchymal stem cell homing factor. Stem Cells 2007, 25, 245-251.
7. Kocher, A.A.; Schuster, M.D.; Szabolcs, M.J.; Takuma, S.; Burkhoff, D.; Wang, J.; Homma, S.; Edwards, N.M.; Itescu, S. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 2001, 7, 430-436.
8. Orlic, D.; Kajstura, J.; Chimenti, S.; Jakoniuk, I.; Anderson, S.M.; Li, B.; Pickel, J.; McKay, R.; Nadal-Ginard, B.; Bodine, D.M.; et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001, 410, 701-705.
9. Makino, S.; Fukuda, K.; Miyoshi, S.; Konishi, F.; Kodama, H.; Pan, J.; Sano, M.; Takahashi, T.; Hori, S.; Abe, H.; et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J. Clin. Invest. 1999, 103, 697-705.
10. Shake, J.G.; Gruber, P.J.; Baumgartner, W.A.; Senechal, G.; Meyers, J.; Redmond, J.M.; Pittenger, M.F.; Martin, B.J. Mesenchymal stem cell implantation in a swine myocardial infarct model: Engraftment and functional effects. Ann. Thorac. Surg. 2002, 73, 1919-1925.
11. Nagaya, N.; Kangawa, K.; Itoh, T.; Iwase, T.; Murakami, S.; Miyahara, Y.; Fujii, T.; Uematsu, M.; Ohgushi, H.; Yamagishi, M.; et al. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 2005, 112, 1128-1135.
12. Mu, Y.; Cao, G.; Zeng, Q.; Li, Y. Transplantation of induced bone marrow mesenchymal stem cells improves the cardiac function of rabbits with dilated cardiomyopathy via upregulation of vascular endothelial growth factor and its receptors. Exp. Biol. Med. 2011, 236, 1100-1107.
13. Yoo, K.J.; Li, R.K.; Weisel, R.D.; Mickle, D.A.; Jia, Z.Q.; Kim, E.J.; Tomita, S.; Yau, T.M. Heart cell transplantation improves heart function in dilated cardiomyopathic hamsters. Circulation 2000, 102, III204-III209.
14. Seth, S.; Narang, R.; Bhargava, B.; Ray, R.; Mohanty, S.; Gulati, G.; Kumar, L.; Reddy, K.S.; Venugopal, P. Percutaneous intracoronary cellular cardiomyoplasty for nonischemic cardiomyopathy: Clinical and histopathological results: The first-in-man ABCD (Autologous Bone Marrow Cells in Dilated Cardiomyopathy) trial. J. Am. Col Cardiol. 2006, 48, 2350-2351.
15. Fischer-Rasokat, U.; Assmus, B.; Seeger, F.H.; Honold, J.; Leistner, D.; Fichtlscherer, S.; Schachinger, V.; Tonn, T.; Martin, H.; Dimmeler, S.; et al. A pilot trial to assess potential effects of selective intracoronary bone marrow-derived progenitor cell infusion in patients with nonischemic dilated cardiomyopathy: Final 1-year results of the transplantation of progenitor cells and functional regeneration enhancement pilot trial in patients with nonischemic dilated cardiomyopathy. Circ. Heart Fail. 2009, 2, 417-423.
16. Smart, N.; Riley, P.R. The stem cell movement. Cir. Res. 2008, 102, 1155-1168.
17. Zhou, Y.L.; Zhang, H.F.; Li, X.L.; Di, R.M.; Yao, W.M.; Li, D.F.; Feng, J.L.; Huang, J.; Cao, K.J.; Fu, M. Increased stromal-cell-derived factor 1 enhances the homing of bone marrow derived mesenchymal stem cells in dilated cardiomyopathy in rats. Chin. Med. J. 2010, 123, 3282-3287.
18. GenBank sequence database. Available online: http://www.ncbi.nlm.nih.gov (accessed on 10 April 2013).
19. Primer3 software. Available online: http://fokker.wi.mit.edu/primer3/input.htm (accessed on 10 April 2013).
20. Bot, I.; Guo, J.; van Eck, M.; van Santbrink, P.J.; Groot, P.H.; Hildebrand, R.B.; Seppen, J.; van Berkel, T.J.; Biessen, E.A. Lentiviral shRNA silencing of murine bone marrow cell CCR2 leads to persistent knockdown of CCR2 function in vivo. Blood 2005, 106, 1147-1153.
21. Zhuang, Y.; Chen, X.; Xu, M.; Zhang, L.Y.; Xiang, F. Chemokine stromal cell-derived factor 1/CXCL12 increases homing of mesenchymal stem cells to injured myocardium and neovascularization following myocardial infarction. Chin. Med. J. 2009, 122, 183-187.
22. Abbott, J.D.; Huang, Y.; Liu, D.; Hickey, R.; Krause, D.S.; Giordano, F.J. Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 2004, 110, 3300-3305.
23. Zhou, H.R.; Kim, E.K.; Kim, H.; Claycombe, K.J. Obesity-associated mouse adipose stem cell secretion of monocyte chemotactic protein-1. Am. J. Physiol. 2007, 293, E1153-E1158.
24. Min, J.Y.; Huang, X.; Xiang, M.; Meissner, A.; Chen, Y.; Ke, Q.; Kaplan, E.; Rana, J.S.; Oettgen, P.; Morgan, J.P. Homing of intravenously infused embryonic stem cell-derived cells to injured hearts after myocardial infarction. J. Thorac. Cardiovasc. Surg. 2006, 131, 889-897.
25. Lin, Y.C.; Leu, S.; Sun, C.K.; Yen, C.H.; Kao, Y.H.; Chang, L.T.; Tsai, T.H.; Chua, S.; Fu, M.; Ko, S.F.; et al. Early combined treatment with sildenafil and adipose-derived mesenchymal stem cells preserves heart function in rat dilated cardiomyopathy. J. Trans. Med. 2010, 8, 88.
26. Askari, A.T.; Unzek, S.; Popovic, Z.B.; Goldman, C.K.; Forudi, F.; Kiedrowski, M.; Rovner, A.; Ellis, S.G.; Thomas, J.D.; DiCorleto, P.E.; et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2003, 362, 697-703.
27. Chamberlain, G.; Wright, K.; Rot, A.; Ashton, B.; Middleton, J. Murine mesenchymal stem cells exhibit a restricted repertoire of functional chemokine receptors: Comparison with human. PLoS One 2008, 3, e2934.
28. Dwyer, R.M.; Potter-Beirne, S.M.; Harrington, K.A.; Lowery, A.J.; Hennessy, E.; Murphy, J.M.; Barry, F.P.; O'Brien, T.; Kerin, M.J. Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells. Clin. Cancer Res. 2007, 13, 5020-5027.
29. Gerard, C.; Rollins, B.J. Chemokines and disease. Nat. Immunol. 2001, 2, 108-115.
30. Rot, A.; von Andrian, U.H. Chemokines in innate and adaptive host defense: Basic chemokinese grammar for immune cells. Annu. Rev. Immunol. 2004, 22, 891-928.
31. Gu, L.; Okada, Y.; Clinton, S.K.; Gerard, C.; Sukhova, G.K.; Libby, P.; Rollins, B.J. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol. Cell 1998, 2, 275-281.
32. Zhong, L.; Chen, W.Q.; Ji, X.P.; Zhang, M.; Zhao, Y.X.; Yao, G.H.; Zhang, P.F.; Zhang, C.; Zhang, Y. Dominant-negative mutation of monocyte chemoattractant protein-1 prevents vulnerable plaques from rupture in rabbits independent of serum lipid levels. J. Cell Mol. Med. 2008, 12, 2362-2371.
33. Birdsall, H.H.; Green, D.M.; Trial, J.; Youker, K.A.; Burns, A.R.; MacKay, C.R.; LaRosa, G.J.; Hawkins, H.K.; Smith, C.W.; Michael, L.H.; et al. Complement C5a, TGF-beta 1, and MCP-1, in sequence, induce migration of monocytes into ischemic canine myocardium within the first one to five hours after reperfusion. Circulation 1997, 95, 684-692.
34. Hayashidani, S.; Tsutsui, H.; Shiomi, T.; Ikeuchi, M.; Matsusaka, H.; Suematsu, N.; Wen, J.; Egashira, K.; Takeshita, A. Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation 2003, 108, 2134-2140.
35. Boyle, A.J.; Yeghiazarians, Y.; Shih, H.; Hwang, J.; Ye, J.; Sievers, R.; Zheng, D.; Palasubramaniam, J.; Palasubramaniam, D.; Karschimkus, C.; et al. Myocardial production and release of MCP-1 and SDF-1 following myocardial infarction: Differences between mice and man. J. Transl. Med. 2011, 9, 150.
36. Fujiyama, S.; Amano, K.; Uehira, K.; Yoshida, M.; Nishiwaki, Y.; Nozawa, Y.; Jin, D.; Takai, S.; Miyazaki, M.; Eqashira, K.; et al. Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells. Cir. Res. 2003, 93, 980-989.